Investing Profile

Noubar Afeyan

VC
Photo of Noubar Afeyan, Managing Partner at Flagship Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Massachusetts Institute of Technology Network
248 CONNECTIONS
McGill University Network
62 CONNECTIONS
Flagship Pioneering Network
27 CONNECTIONS
MIT Sloan School of Management Network
15 CONNECTIONS
cb
Flagship Ventures Managing Partner
53
$824M
CompanyStageDateRound SizeTotal Raised
Serif Bio­med­i­cines
Series UnknownApr 2026$50M
$50M
Extuitive
SeedSep 2025$20M
$20M
Terrana Biosciences
Series BJul 2025$50M
$50M
Prologue Medicines
Series AMay 2024$50M
$50M
Quotient Therapeutics
SeedNov 2023$50M
$50M
Generate Biomedicines
Series CSep 2023$270M
Series BNov 2021$370M
$640M
Alltrna
Series BAug 2023$110M
Series UnknownNov 2021$50M
$160M
Empress Therapeutics
Series UnknownJun 2023$50M
$50M
Co-investors: Doug Cole (Flagship Ventures)
Co-Founder Indigo2013 - Present
Chairman and Co-Founder Moderna Therapeutics2010 - Present
Chairman and Co-Founder Axcella Health2010 - Present
Founder, CEO and Senior Managing Partner Flagship Pioneering2000 - Present
Chairman and Co-Founder Joule Unlimited Technologies, Inc.2007 - 2017
Senior Lecturer MIT Sloan School of Management2000 - 2016
Chairman and Co-Founder Ensemble Therapeutics Corporation2002 - 2016
CEO and Founder PerSeptive Biosystems1989 - 2008
Chairman and Co-founder Codon Devices2004 - 2007
Co-founder Epitome Biosystems2003 - 2005
Chief Business Officer Applera Corporation1998 - 1999
Co-Founder Celera Genomics1998 - 1999
Chairman and Co-Founder Chemgenics Pharmaceuticals1995 - 1997
Massachusetts Institute of Technology PhD Biochemical Engineering
McGill University BS Chemical Engineering